Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ARCT
ARCT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ARCT News
Arcturus Therapeutics Shares Rise 5.7% Following Collaboration with Thermo Fisher
5d ago
NASDAQ.COM
Arcturus Partners with Thermo Fisher to Advance Cystic Fibrosis Therapy
6d ago
seekingalpha
Arcturus and Thermo Fisher Forge Strategic Manufacturing Agreement
6d ago
Newsfilter
Arcturus Therapeutics Q1 2026 Earnings Call Insights
May 08 2026
seekingalpha
Arcturus Therapeutics Q1 Earnings Analysis
May 07 2026
seekingalpha
Arcturus Therapeutics Set to Announce Q1 Earnings on May 7
May 06 2026
seekingalpha
Transformation of Value in Biotechnology Sector
Apr 20 2026
Globenewswire
Biotechnology Sector Undergoes Value Transformation
Apr 20 2026
Newsfilter
Cathie Wood Increases Holdings in Three Stocks Amid Market Volatility
Mar 25 2026
Fool
Cathie Wood Quietly Adds to Three Stocks Amid Market Decline
Mar 23 2026
Fool
Cathie Wood Increases Stakes in Figma, Arcturus, and 10x Genomics
Mar 23 2026
NASDAQ.COM
Arcturus Therapeutics Q4 2025 Earnings Call Insights
Mar 04 2026
seekingalpha
Arcturus Therapeutics Reports Disappointing Earnings
Mar 03 2026
seekingalpha
Arcturus Therapeutics Set to Announce Q4 Earnings on March 3rd
Mar 02 2026
seekingalpha
Arcturus to Present mRNA Technologies at J.P. Morgan Healthcare Conference
Jan 08 2026
Businesswire
Arcturus Announces Launch of 12-Week Cystic Fibrosis Study in 2026, Facing Cost Management and KOSTAIVE BLA Delays
Nov 10 2025
SeekingAlpha
Show More News
